ReviewCold Spring Harbor perspectives in medicine2016

Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.

Jennifer A LeedsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.